dr lal pathlabs

Saurabh Mukherjea, Founder, Marcellus Investment Managers, says ROC and free cash flow are proxies. While ROC can drive, Divi’s promoter has distinctive capabilities. One has to look…
Read More...

Indian market opened on a firm note on Thursday, tracking positive global cues. S&P BSE Sensex declined more than 600 points while Nifty50 closed below 18,200 on Wednesday. Indian…
Read More...

Global brokerage JPMorgan maintained an overweight rating on , Credit Suisse initiated underperform rating on and Goldman Sachs maintained a buy on . We have collated a list of…
Read More...

Mumbai: Antique Stock Broking has initiated coverage on diagnostic chains Dr Lal PathLabs and Metropolis Healthcare with sell ratings. The brokerage has set a price target of ₹1,643 on…
Read More...

Indian markets started on a strong note on Thursday followed by the positive trends seen in other Asian markets. The S&P BSE Sensex rallied more than 300 points while the Nifty50…
Read More...

New Delhi: The last week of June was a mixed bag for domestic equity markets as benchmark indices settled with marginal gains. Weak rupee, FII numbers, looming fear of recession and…
Read More...

NEW DELHI: The stock market continues to reel under heavy selling pressure. There are numerous headwinds that investors and traders are dealing with and their plight may not end soon,…
Read More...